Tushar S Garimella

Title: Tushar S Garimella: Innovator in ADHD Treatment

Introduction

Tushar S Garimella is a notable inventor based in Skokie, IL (US). He has made significant contributions to the field of pharmacology, particularly in the treatment of attention-deficit/hyperactivity disorder (ADHD). His innovative work has led to the development of compounds that target nicotinic receptors, providing new avenues for managing ADHD symptoms.

Latest Patents

Garimella holds a patent for the treatment of ADHD, specifically for the compound 3-(5,6-Dichloro-pyridin-3-yl)-1S,5S-3,6-diazabicyclo[3.2.0]heptane and its salts. This compound has demonstrated pharmacological effects that are beneficial for individuals suffering from ADHD. His patent portfolio includes 1 patent that showcases his commitment to advancing medical treatments.

Career Highlights

Tushar S Garimella is associated with Abbott Laboratories Corporation, a leading global healthcare company. His role at Abbott has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts. His work is characterized by a focus on innovative solutions to complex health issues.

Collaborations

Garimella has worked alongside esteemed colleagues such as Sandeep Dutta and Earle E Bain. These collaborations have enriched his research and have been instrumental in the development of effective treatments for ADHD.

Conclusion

Tushar S Garimella is a pioneering inventor whose work in ADHD treatment exemplifies the impact of innovation in healthcare. His contributions continue to influence the field and offer hope for improved management of ADHD symptoms.